# Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial

> **NCT00373048** · NA · COMPLETED · sponsor: **Institute of Tropical Medicine, Belgium** · enrollment: 300 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** mefloquine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00373048
- **Lead sponsor:** Institute of Tropical Medicine, Belgium
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2007-12
- **Final completion:** 2011-05
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2011-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00373048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00373048, "Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT00373048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*